Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Systemic lupus erythematosus | R-HSA-977105 | map05322 | hexestrol | 192197 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | hexestrol | 192197 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | hexestrol | 192197 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | hexestrol | 192197 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | hexestrol | 192197 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | hexestrol | 192197 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | hexestrol | 192197 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | hexestrol | 192197 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | halofantrine | 5280443 | drug-path |
Hedgehog signaling pathway | R-HSA-5358351 | map04340 | halofantrine | 5280443 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | halofantrine | 5280443 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | alpha-ergocryptine | 134551 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | alpha-ergocryptine | 134551 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | alpha-ergocryptine | 134551 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | alpha-ergocryptine | 134551 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | alpha-ergocryptine | 134551 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | alpha-ergocryptine | 134551 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | alpha-ergocryptine | 134551 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | alpha-ergocryptine | 134551 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | alpha-ergocryptine | 134551 | drug-path |